Schizophrenia-Spectrum Disorders



Schizophrenia-Spectrum Disorders







“It’s tough to make predictions, especially about the future.”

Yogi Berra, baseball Hall of Famer, 1972

The father of psychiatric nosology, Emil Kraepelin, divided severe psychiatric disorders into the episodic mood disorders (i.e., manic-depressive illness or bipolar disorder) and nonepisodic psychotic disorders (i.e., dementia praecox or schizophrenia). Now, 100 years later, we still use this fundamental dichotomy. In his scheme, schizophrenia is the prototypical psychotic illness marked by prominent psychosis in the absence of psychiatric or medical disorders that would explain psychosis; patients who have this disease suffer from some degree of social impairment. In the real world of clinical
cases, patients do not always fit the syndrome of schizophrenia: Some patients experience short periods of illness without obvious impairment; others display rather significant admixtures of mood symptoms. To include cases on the edges of narrowly defined schizophrenia, the term “schizophrenia-spectrum conditions” is sometimes used, although disagreement on what conditions to include persists (e.g., some would include schizotypal personality disorder, others delusional disorder) (see Table 6.1 for the use in this book). Yet another term, “nonaffective psychoses” similarly refers to a spectrum of psychotic disorders that includes all psychotic disorders except those in which psychosis is part of a primary mood disorder.

In this chapter I provide a clinical description of the syndrome of schizophrenia that focuses on its natural history. How to make a clinical diagnosis of schizophrenia using current diagnostic criteria is presented in the next chapter.


SCHIZOPHRENIA

The natural history of schizophrenia can be divided into several phases. A stable and clinically asymptomatic premorbid phase gives way to a prodromal period with progressive yet unspecific symptoms until frank psychosis develops. About 50% of patients will become ill between ages 15 and 25, and about 80% between ages 15 and 35. Gender differences exist: More males than females are affected, and females have a later onset (by about 3 to 4 years) and a less virulent disease.


Schizophrenia Prodrome


In medicine, many illnesses are preceded by an unspecific prodromal state during which no diagnosis can be made (e.g., erythema infectiosum or fifth disease, roseola infantum) until
certain diagnostic symptoms (telltale rash) appear. Similarly, the full syndrome of schizophrenia with frank psychosis is preceded in most cases by a prodrome that varies in length from several weeks to years. The prodrome can be divided into two phases: a prepsychotic phase and a phase of low-grade, attenuated psychosis that marks the transition to full-blown psychosis. The prepsychotic phase is marked by varied and unspecific symptoms that often result in a psychiatric evaluation and some treatment, usually for depression (Table 7.1). Not only are prodromal symptoms unspecific, but they are also prevalent in normal populations. In one survey of 657 normal 16-year-old high school students, individual prodromal symptoms were endorsed at rates reaching 50% (McGorry et al., 1995).

This prodromal phase of schizophrenia has received much attention, as there is hope that treatment during the prodrome might prevent schizophrenia or ameliorate its effects if treated earlier. The most problematic aspect of treatment during a presumed prodrome is the treatment of patients who will never go on to develop schizophrenia. From prospective studies, we know that only about half of high-risk, presumably prodromal patients will actually develop the full syndrome of schizophrenia. One double-blind trial has shown that olanzapine 5 to 15 mg per day for 1 year given to patients presumed to be prodromal cuts the conversion rate to schizophrenia by half (McGlashan et al., 2006). It is currently unclear what to do beyond 1 year, as it is not clear if the treatment with olanzapine prevents schizophrenia or simply delays the full syndrome.

At this point, close clinical follow-up with symptomatic treatment (e.g., antidepressant for depression) in patients who have a genetic risk for schizophrenia and who develop a decline in function (but no psychosis) is the recommended
approach. To intervene at the earliest sign of psychosis, long-term follow-up is very important for patients at high risk for schizophrenia.








TABLE 7.1. Common Prodromal Symptoms of Schizophrenia

















Difficulties with concentration


Decreased motivation


Depression


Anxiety and irritability


Difficulties sleeping


Role failure


Social withdrawal

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 12, 2016 | Posted by in PSYCHIATRY | Comments Off on Schizophrenia-Spectrum Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access